# Sustained zinc release in cooperation with CaP scaffold promoted bone regeneration via directing stem cell fate and triggering a pro-healing immune stimuli

**Authors:** Xin Huang, Donghua Huang, Ting Zhu, Xiaohua Yu, Kaicheng Xu, Hengyuan Li, Hao Qu, Zhiyuan Zhou, Kui Cheng, Wenjian Wen, Zhaoming Ye

PMC · DOI: 10.1186/s12951-021-00956-8 · Journal of Nanobiotechnology · 2021-07-12

## TL;DR

Zinc ions in a special scaffold help bone regeneration by promoting stem cell differentiation and encouraging healing immune responses.

## Contribution

This study reveals how zinc ions synergistically enhance bone healing through osteoinductive and immunomodulatory effects.

## Key findings

- Zn2+ enhances osteogenic differentiation of progenitor cells and promotes M2 macrophage polarization.
- Zn2+ induces M2 polarization via the PI3K/Akt/mTOR pathway.
- Zn2+-releasing scaffolds show pro-healing effects in vivo using rat models.

## Abstract

Metal ions have been identified as important bone metabolism regulators and widely used in the field of bone tissue engineering, however their exact role during bone regeneration remains unclear. Herein, the aim of study was to comprehensively explore the interactions between osteoinductive and osteo-immunomodulatory properties of these metal ions. In particular, the osteoinductive role of zinc ions (Zn2+), as well as its interactions with local immune microenvironment during bone healing process, was investigated in this study using a sustained Zn2+ delivery system incorporating Zn2+ into β-tricalcium phosphate/poly(L-lactic acid) (TCP/PLLA) scaffolds. The presence of Zn2+ largely enhanced osteogenic differentiation of periosteum-derived progenitor cells (PDPCs), which was coincident with increased transition from M1 to M2 macrophages (M\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\varphi $$\end{document}φs). We further confirmed that induction of M2 polarization by Zn2+ was realized via PI3K/Akt/mTOR pathway, whereas marker molecules on this pathway were strictly regulated by the addition of Zn2+. Synergically, this favorable immunomodulatory effect of Zn2+ further improved the osteogenic differentiation of PDPCs induced by Zn2+ in vitro. Consistently, the spontaneous osteogenesis and pro-healing osteoimmunomodulation of the scaffolds were thoroughly identified in vivo using a rat air pouch model and a calvarial critical-size defect model. Taken together, Zn2+-releasing bioactive ceramics could be ideal scaffolds in bone tissue engineering due to their reciprocal interactions between osteoinductive and immunomodulatory characteristics. Clarification of this synergic role of Zn2+ during osteogenesis could pave the way to develop more sophisticated metal-ion based orthopedic therapeutic strategies.

The online version contains supplementary material available at 10.1186/s12951-021-00956-8.

## Linked entities

- **Chemicals:** Zn2+ (PubChem CID 32051)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Cd40 (CD40 antigen) [NCBI Gene 21939] {aka Bp50, GP39, HIGM1, IGM, IMD3, T-BAM}, Smad1 (SMAD family member 1) [NCBI Gene 17125] {aka Mad1, Madh1, Madr1, Mlp1, MusMLP, dwf-A}, Cd44 (CD44 molecule) [NCBI Gene 25406] {aka CD44A, METAA, RHAMM}, Mtr (5-methyltetrahydrofolate-homocysteine methyltransferase) [NCBI Gene 81522] {aka methioninesynthase}, Actb (actin, beta) [NCBI Gene 81822] {aka Actx}, Ptprc (protein tyrosine phosphatase, receptor type, C) [NCBI Gene 24699] {aka CD45, L-CA, Lca, RT7, T200}, BMP2 (bone morphogenetic protein 2) [NCBI Gene 650] {aka BDA2, BMP2A, SSFSC, SSFSC1}, Thy1 (Thy-1 cell surface antigen) [NCBI Gene 24832] {aka CD7}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Nos2 (nitric oxide synthase 2) [NCBI Gene 24599] {aka Nos2a, iNos}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 59086] {aka Tgfb}, Pecam1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 29583] {aka CD31, Pecam}, Bmp2 (bone morphogenetic protein 2) [NCBI Gene 12156] {aka Bmp2a}, Il4 (interleukin 4) [NCBI Gene 287287] {aka Il4e12}, Bglap2 (bone gamma-carboxyglutamate protein 2) [NCBI Gene 12097] {aka BGP2, Bglap1, Bgp, Og2, mOC-B}, ALPP (alkaline phosphatase, placental) [NCBI Gene 250] {aka ALP, PALP, PLAP, PLAP-1}, Akt1 (AKT serine/threonine kinase 1) [NCBI Gene 24185] {aka Akt}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 24383] {aka BARS-38, Gapd}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56718] {aka Frap1, RAFT1}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Bmp2 (bone morphogenetic protein 2) [NCBI Gene 29373], Smad1 (SMAD family member 1) [NCBI Gene 25671] {aka Madh1}, Bglap (bone gamma-carboxyglutamate protein) [NCBI Gene 25295] {aka Bglap2, Bgp, Bgpr, Bgpra}, Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Mrc1 (mannose receptor, C type 1) [NCBI Gene 17533] {aka CD206, MR}
- **Diseases:** Ms (MESH:D055501), PDPCs (MESH:D002292), inflammation (MESH:D007249), PE (MESH:C580424), H&amp;E (MESH:D016751), bone defect (MESH:D001847), defects (MESH:D000013), cytotoxic (MESH:D064420), Zn deficiency (MESH:C564286), infection (MESH:D007239)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** PDPCs — Homo sapiens (Human), Transformed cell line (CVCL_VI04), RAW 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), S1J-L — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_AV88), THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC8274038/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC8274038/full.md

## References

94 references — full list in the complete paper: https://tomesphere.com/paper/PMC8274038/full.md

---
Source: https://tomesphere.com/paper/PMC8274038